Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Varex Imaging CorpVREX · Entity 5135 | SVP and GM, Detectors | December 15, 2025 | December 17, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Varex Imaging Corp
Report date December 15, 2025 · Filed December 17, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,178 |
Reported balance
After 2025-12-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-15 · Grant · Acquired 2,565 · Balance 4,178 F1: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F2: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,134 |
Reported balance
After 2025-12-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-15 · Grant · Acquired 3,134 · Balance 3,134 F1: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F3: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria.
F2: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.
F3: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2025 Filed Dec 17, 2025 21:34 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantPerformance Stock Units · Derivative | 3,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000137 · wk-form4_1766007245.xml · derivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,134 Underlying: Common Stock · 3,134 shares Expires not disclosed F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F3 · derivative.exercise_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. F3 · derivative.expiration_date: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:34 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantPerformance Stock Units · Derivative | 2,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000137 · wk-form4_1766007245.xml · derivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,178 Underlying: Common Stock · 2,565 shares Expires not disclosed F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F2 · derivative.exercise_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. F2 · derivative.expiration_date: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 22:11 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 26,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000126 · wk-form4_1765577497.xml · derivative · entry 6 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,401 Underlying: Common Stock · 26,041 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 22:11 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 7,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000126 · wk-form4_1765577497.xml · derivative · entry 5 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,936 Underlying: Common Stock · 7,935 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% and are scheduled to vest 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% and are scheduled to vest 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 22:11 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 4,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000126 · wk-form4_1765577497.xml · derivative · entry 4 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,664 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vested 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vested 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 22:11 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 3,636 | $11.70 | $42,541.20 |
DisclosureSEC source: 0001681622-25-000126 · wk-form4_1765577497.xml · nonDerivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,182 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 22:11 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 7,935 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-25-000126 · wk-form4_1765577497.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 22:11 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 4,664 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-25-000126 · wk-form4_1765577497.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2025 Filed Feb 20, 2025 01:30 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 5,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-25-000037 · wk-form4_1740015045.xml · derivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,762 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on February 16, 2021, vested 50% on February 15, 2023, and 50% on February 15, 2025. F4 · derivative.expiration_date: These Restricted Stock Units granted on February 16, 2021, vested 50% on February 15, 2023, and 50% on February 15, 2025. Read SEC document |
| February 15, 2025 Filed Feb 20, 2025 01:30 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 2,720 | $13.27 | $36,094.40 |
DisclosureSEC source: 0001681622-25-000037 · wk-form4_1740015045.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,219 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2025 Filed Feb 20, 2025 01:30 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 5,762 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-25-000037 · wk-form4_1740015045.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On February 16, 2021, the Reporting Person was granted 11,523 Restricted Stock Units, 50% of which vested on February 15, 2023, and 50% of which vested on February 15, 2025. F2 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 01:16 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantPerformance Stock Units · Derivative | 1,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000116 · wk-form4_1734570982.xml · derivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,613 Underlying: Common Stock · 1,613 shares Expires not disclosed F1 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F2 · derivative.exercise_date: On December 10, 2023, the Reporting Person was granted PSUs, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSUs that were earned as a result of the achievement of such performance criteria. Following the completion of Fiscal Year 2026, the Compensation Committee will certify and approve the total number of PSUs that were earned, and such PSUs will vest subject to the Reporting Person being employed through the vesting date. F2 · derivative.expiration_date: On December 10, 2023, the Reporting Person was granted PSUs, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSUs that were earned as a result of the achievement of such performance criteria. Following the completion of Fiscal Year 2026, the Compensation Committee will certify and approve the total number of PSUs that were earned, and such PSUs will vest subject to the Reporting Person being employed through the vesting date. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 21:41 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 6,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000098 · wk-form4_1734039671.xml · derivative · entry 4 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,523 Underlying: Common Stock · 6,523 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on December 9, 2022 vest 50% on December 10, 2024 and 50% on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on December 9, 2022 vest 50% on December 10, 2024 and 50% on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 21:41 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 14,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000098 · wk-form4_1734039671.xml · derivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,368 Underlying: Common Stock · 14,368 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2024 vest 50% on December 10, 2026 and 50% on December 10, 2028. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2024 vest 50% on December 10, 2026 and 50% on December 10, 2028. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 21:41 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 2,734 | $15.45 | $42,240.30 |
DisclosureSEC source: 0001681622-24-000098 · wk-form4_1734039671.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,177 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 21:41 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 6,523 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-24-000098 · wk-form4_1734039671.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:40 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 5,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000043 · wk-form4_1708465198.xml · derivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,135 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units vested on February 15, 2024 and were part of a grant made to the reporting person on February 18, 2020. The vested shares were delivered to the reporting person on the vesting date. F3 · derivative.expiration_date: The Restricted Stock Units vested on February 15, 2024 and were part of a grant made to the reporting person on February 18, 2020. The vested shares were delivered to the reporting person on the vesting date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:40 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 2,429 | $17.40 | $42,264.60 |
DisclosureSEC source: 0001681622-24-000043 · wk-form4_1708465198.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,388 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:40 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 5,135 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-24-000043 · wk-form4_1708465198.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 22:54 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 4,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000086 · wk-form4_1702421647.xml · derivative · entry 4 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,664 Underlying: Common Stock · 4,664 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 22:54 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 15,871 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000086 · wk-form4_1702421647.xml · derivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,742 Underlying: Common Stock · 15,871 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2023 vest 50% on December 10, 2025 and 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2023 vest 50% on December 10, 2025 and 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 22:54 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 1,959 | $19.69 | $38,572.71 |
DisclosureSEC source: 0001681622-23-000086 · wk-form4_1702421647.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,682 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 22:54 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 4,664 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-23-000086 · wk-form4_1702421647.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 10, 2021, the Reporting Person was granted 9,328 Restricted Stock Units, 50% of which vested on December 10, 2023 and 50% of which vest on December 10, 2025. F2 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:13 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 5,761 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000039 · wf-form4_167667200995320.xml · derivative · entry 5 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,762 Underlying: Common Stock · 5,761 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on February 16, 2021 vest 50% on February 15, 2023 and 50% on February 15, 2025. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on February 16, 2021 vest 50% on February 15, 2023 and 50% on February 15, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:13 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000039 · wf-form4_167667200995320.xml · derivative · entry 4 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,623 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:13 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 2,466 | $18.82 | $46,410.12 |
DisclosureSEC source: 0001681622-23-000039 · wf-form4_167667200995320.xml · nonDerivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,977 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:13 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 5,761 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-23-000039 · wf-form4_167667200995320.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:13 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,623 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-23-000039 · wf-form4_167667200995320.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 23:15 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 13,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000097 · wf-form4_167097331413632.xml · derivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,046 Underlying: Common Stock · 13,046 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on December 9, 2022 vest 50% on December 10, 2024 and 50% on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on December 9, 2022 vest 50% on December 10, 2024 and 50% on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 23:15 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 27,033 | $0.00 Strike: $22.13 | $0.00 |
DisclosureSEC source: 0001681622-22-000097 · wf-form4_167097331413632.xml · derivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,033 Underlying: Common Stock · 27,033 shares Expires 2032-12-09 F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest on December 10, 2023, and the remaining options vest monthly thereafter on the 10th day of each month on a pro rata basis. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:57 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000073 · wf-form4_166069061117432.xml · derivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units granted on August 24, 2018 vest 25% each year for four years beginning on August 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: The Restricted Stock Units granted on August 24, 2018 vest 25% each year for four years beginning on August 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:57 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 724 | $22.31 | $16,152.44 |
DisclosureSEC source: 0001681622-22-000073 · wf-form4_166069061117432.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,059 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:57 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,638 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000073 · wf-form4_166069061117432.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:06 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 5,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · derivative · entry 5 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,135 Underlying: Common Stock · 5,134 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:06 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · derivative · entry 4 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,623 Underlying: Common Stock · 1,623 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:06 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 3,206 | $23.47 | $75,244.82 |
DisclosureSEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · nonDerivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,145 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:06 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 5,134 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:06 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,623 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 23:45 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 9,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000110 · wf-form4_163952548818987.xml · derivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,328 Underlying: Common Stock · 9,328 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 23:45 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 21,748 | $0.00 Strike: $30.95 | $0.00 |
DisclosureSEC source: 0001681622-21-000110 · wf-form4_163952548818987.xml · derivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,748 Underlying: Common Stock · 21,748 shares Expires 2031-12-10 F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest one year from grant date, and the remaining options vest monthly thereafter on a pro rata basis. Read SEC document |
| August 13, 2021 Filed Aug 18, 2021 23:52 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000090 · wf-form4_162933069179001.xml · derivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,638 Underlying: Common Stock · 1,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units granted on August 24, 2018 vest 25% each year for four years beginning on August 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: The Restricted Stock Units granted on August 24, 2018 vest 25% each year for four years beginning on August 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| August 13, 2021 Filed Aug 18, 2021 23:52 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 480 | $27.58 | $13,238.40 |
DisclosureSEC source: 0001681622-21-000090 · wf-form4_162933069179001.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,594 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| August 13, 2021 Filed Aug 18, 2021 23:52 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000090 · wf-form4_162933069179001.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 23:41 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 28,195 | $0.00 Strike: $25.06 | $0.00 |
DisclosureSEC source: 0001681622-21-000048 · wf-form4_161369166587323.xml · derivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,195 Underlying: Common Stock · 28,195 shares Expires 2031-02-16 F3 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest one year from grant date, and the remaining options vest monthly thereafter on a pro rata basis. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 23:41 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 11,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000048 · wf-form4_161369166587323.xml · derivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,523 Underlying: Common Stock · 11,523 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Restricted Stock Units granted on February 16, 2021 vest 50% on February 15, 2023 and 50% on February 15, 2025. Vested shares will be delivered to the reporting person upon vest date. F2 · derivative.expiration_date: These Restricted Stock Units granted on February 16, 2021 vest 50% on February 15, 2023 and 50% on February 15, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.